Flow Cytometric Analysis of the Expression of Fas/Fasl in Bone Marrow CD34⁺ Cells in Myelodysplastic Syndromes: Relation to Disease Progression

References

• Kitagawa, M., Yamaguchi, S., Takahashi, M., Hirokawa, K. and Kamiyama, R. (1998) "Localization of Fas and Fas ligand in bone marrow cells demonstrating myelodysplasia", Leukemia, 12, 486–492.
   Google Scholar
• Yoshida, Y. and Mufti, G.J. (1999) "Apoptosis and its significance in MDS: controversies revisited", Leukemia Research, 23, 777–785.
   PubMed Web of Science ®Google Scholar
• Bouscary, D., De Vos, J., Guesnu, M., Jondeau, K., Viguier, F., Melle, J., et al. (1997) "Fas/Apo-1(CD95) expression and apoptosis in patients with myelodysplastic syndromes", Leukemia, 11, 839–845.
   PubMed Web of Science ®Google Scholar
• Parker, J.E., Mufti, G.J., Rassol, F., Mijovic, A., Devereux, S. and Pagliuca, A. (2000) "The role of apoptosis, proliferation and the bcl-2-related proteins in the myelodysplastic syndromes and acute myeloid leukemia secondary to MDS", Blood, 96, 3932–3938.
   PubMed Web of Science ®Google Scholar
• Greenberg, P.L. (1998) "Apoptosis and its role in the myelodys-plastic syndromes: implications for disease natural history and treatment", Leukemia Research, 22, 1123–1136.
   Google Scholar
• Bogdanovic, AD., Trpinac, D.P., Jankovic, G.M., Bumbasirevic, V.Z., Obradovic, M. and Colovic, M.D. (1997) "Incidence and role of apoptosis in myelodysplastic syndrome: morphological and ultrastructural assessment", Leukemia, 11, 656–659.
   PubMed Web of Science ®Google Scholar
• Mundle, S., Venugopal, P., Shetty, V., Ali, A., Chopra, H., Handa, H., et al. (1999) "The relative extend and propensity of CD34 vs. CD34 - cells to undergo apoptosis in myelodysplastic marrows", International Journal of Haematology, 9, 152–159.
   PubMed Web of Science ®Google Scholar
• Tsoplou, P., Kouraklis, AS., Thanopoulou, E., Zikos, P., Orphanos, V. and Zoumbos, N.C. (1999) "Apoptosis in patients with myelodysplastic syndromes: differential involvement if marrow cells in "good" versus "poor" prognosis patients and correlation with apoptosis-related genes", Leukemia, 13, 1554–1563.
   Google Scholar
• Rajapaksa, R., Ginzton, N., Lusijah, S.R. and Greenberg, P.L. (1996) "Altered oncoprotein expression and apoptosis in myelodys-plastic syndrome marrow cells", Blood, 88, 4275–4287.
   Google Scholar
• Munker, R., Midis, G., Owen-Schaub, L. and Andreff, M. (1996) "Soluble Fas (CD95) is not elevated in the serum of patients with myeloid leukemias, myeloproliferative and myelodysplastic syn-dromes", Leukemia, 10, 1531.
   Google Scholar
• Gersuk, G.M., Beckham, C., Loken, MR., Kiener, P., Anderson, J.E., Farrand, A., et al. (1998) "A role for tumor necrosis factor-a, Fas and Fas-ligand in marrow failure associated with myelodys-plastic syndrome", British Journal of Haematology, 103, 176.
   Google Scholar
• Harris, N.L., Jeffe, ES., Diebold, J., Flandring, G., Muller-Hermelink, H.K. and Vardiman, J. (2000) "The World Health Organization classification of neoplastic diseases of the haemato-poetic and lymphoid tissues: report of the clinical advisory comittee meeting, Airlie House, Virginia", Histopathology, 36, 69–87.
   PubMedGoogle Scholar
• Irazusta, S.P., Vassallo, J., Magna, L.A., Metze, K. and Trevisan, M. (1998) "The value of PCNA and AgNOR staining in endoscopic biopsies of gastric mucosa", Pathology Research and Practice, 194, 33–39.
   Google Scholar
• Lorand-Metze, I., Meira, D.G., Lima, C.S.P., Vassallo, J. and Metze, K. (1998) "The differential diagnosis between aplastic anemia and hypocellular myelodysplasia in patients with pancyto-penia", Haematologica, 84, 564–565.
   Google Scholar
• Metze, K., Lobo, A.M. and Lorand-Metze, I. (2000) "Nucleolus organizer regions (AgNORs) and total tumor mass are independent prognostic parameters for treatment-free period in chronic lympho-cytic leukemia", International Journal of Cancer, 89, 440–443.
   Google Scholar
• Elghetany, M.T. (1998) "Surface marker abnormalities in myelo-dysplastic syndromes", Haematologica, 83, 1104–1115.
   Google Scholar
• Del Cafiizo, MC., Fernandez, E., Lopez, A., Vidriales, B., Villaron, E., Arroyo, J.L., et al. (2003) "Immunophenotypic analysis of myelodysplastic syndromes", Haematologica, 88, 402–407.
   PubMed Web of Science ®Google Scholar
• Fuchigami, K., Mori, H., Matsuo, T., Iwanaga, M., Nagai, K., Kuriyama, K., et al. (1999) "Absolute number of circulating CD34 cells is abnormally low in refractory anemias and extremely high in RAEB and RAEB-t; novel pathologic features of myelodysplastic syndromes identified by highly sensitive flow cytometry", Leukemia Research, 24, 163–174.
   Web of Science ®Google Scholar
• Oliveira, GB., Pereira, F.G., Metze, K. and Lorand-Metze, I. (2001) Spontaneous apoptosis in chronic lymphocytic leukemia and its relationship to clinical and cell kinetic parameters. Cytometry (CCC), 46, 329–335.
   Google Scholar
• Vassallo, J., Metze, K., Traina, F., Souza, C.A. and Lorand-Metze, I. (2003) "The prognostic relevance of apoptosis-related proteins in classical Hodgkin's lymphomas", Leukemia & Lymphoma, 44,483–488.
   Google Scholar
• Ribeiro, E., Lima, C.S.P., Metze, K., Souza, C.A. and Lorand-Metze, I. (2003) "Changes in the hemopoietic precursors after treatment of low-risk myelodysplasia with amifostine", In vivo, 17, 181–184.
   Google Scholar
• Shimazaki, K., Ohshima, K., Suzumiya, J., Kawasaki, C. and Kikuchi, M. (2002) "Apoptosis and prognostic factors in myelo-dysplastic syndromes", Leukemia & Lymphoma, 43, 257–260.
   Web of Science ®Google Scholar
• Gupta, P., Niehans, GA., LeRoy, S.C., Gupta, K., Morrison, V.A., Schultz, C., Knapp, DJ. and Kratzke R.A. (1999) "Fos ligand expression in the bone marrow in myelodysplastic syndromes correlates with FAB subtype and anemia and predicts survival", Leukemia, 13, 44–53.
   PubMed Web of Science ®Google Scholar
• Mundle, S., Venugopal, P., Shetty, V., Ali, A., Chopra, H., Handa, H., et al. (1999) "The relative extend and propensity of CD34 vs CD34 - cells to undergo apoptosis in myelodysplastic marrows", International Journal of Haematology, 9, 152–159.
   PubMed Web of Science ®Google Scholar
• Ramos, F., Fuertes-Nufiez, M., SuOrez-Vilela, D. and Fernandez-Lopez, A. (2002) "What does apoptosis have to do with clinical features in myelodysplastic syndrome"? Haematologica, 87, 381–391.
   Google Scholar
• Choi, J.W. (2002) "Apoptotic rate varies with detection methods in myelodysplastic syndromes: impact of method selection", European Journal of Haematology, 69, 62–63.
   PubMed Web of Science ®Google Scholar
• Deeg, R.I., Beckham, MR., Loken, MR., Bryant, E., Lennikova, M., Shulman, H., et al. (2000) "Negative regulators of hemopoiesis and stroma function in patients with myelodysplastic syndrome", Leukemia & Lymphoma, 37, 405–414.
   PubMed Web of Science ®Google Scholar